Mizumoto K, Muroya K, Takagi T, Omata-Yamada T, Shibuta H, Iwasaki K
School of Pharmaceutical Sciences, Kitasato University, Tokyo.
J Biochem. 1995 Mar;117(3):527-34. doi: 10.1093/oxfordjournals.jbchem.a124740.
To elucidate the mechanism of transcription and replication of Sendai virus, we developed an efficient and faithful in vitro transcription system using purified virus particles. The in vitro RNA synthesis was almost entirely dependent on the addition of eukaryotic cell extracts, including those from various cultured mammalian cells, mammalian tissues, and even from plant cells. The RNA products were almost identical to authentic mRNA species synthesized in the infected cells, in their size distribution, the presence of 3'-poly(A) tail and the presence of methylated 5'-cap structure (m7GpppAm). Ribonuclease protection experiments after annealing the in vitro RNA with viral genomic RNA (vRNA) indicated that the virion-associated RNA-dependent RNA polymerase transcribes correct regions of the RNA genome in vitro. The active component(s) that is required for Sendai virus mRNA synthesis was partially purified from bovine brain and was separated into at least two complementary fractions, one of which could be replaced by highly purified cellular tubulin. When viral ribonucleoprotein complexes were used instead of virus particles in the in vitro transcription, only Sendai virus-infected cell extracts supported mRNA synthesis, and extracts from uninfected cells or cells infected with other viruses were found to be inert. These results suggest that, in addition to the general factors which are present ubiquitously in eukaryotic cells, a factor(s) specific to Sendai virus-infection is required for Sendai virus transcription.
为阐明仙台病毒转录和复制的机制,我们利用纯化的病毒颗粒建立了一种高效且可靠的体外转录系统。体外RNA合成几乎完全依赖于添加真核细胞提取物,包括来自各种培养的哺乳动物细胞、哺乳动物组织甚至植物细胞的提取物。RNA产物在大小分布、3'-多聚腺苷酸尾的存在以及甲基化5'-帽结构(m7GpppAm)的存在方面,几乎与感染细胞中合成的真实mRNA种类相同。将体外RNA与病毒基因组RNA(vRNA)退火后的核糖核酸酶保护实验表明,病毒粒子相关的RNA依赖性RNA聚合酶在体外转录RNA基因组的正确区域。从牛脑中部分纯化了仙台病毒mRNA合成所需的活性成分,并将其分离成至少两个互补部分,其中一个部分可以被高度纯化的细胞微管蛋白替代。当在体外转录中使用病毒核糖核蛋白复合物而非病毒颗粒时,只有感染仙台病毒的细胞提取物支持mRNA合成,而未感染细胞或感染其他病毒的细胞提取物则无活性。这些结果表明,除了真核细胞中普遍存在的一般因子外,仙台病毒转录还需要仙台病毒感染特异性的因子。